JP2024535034A5 - - Google Patents
Info
- Publication number
- JP2024535034A5 JP2024535034A5 JP2024516626A JP2024516626A JP2024535034A5 JP 2024535034 A5 JP2024535034 A5 JP 2024535034A5 JP 2024516626 A JP2024516626 A JP 2024516626A JP 2024516626 A JP2024516626 A JP 2024516626A JP 2024535034 A5 JP2024535034 A5 JP 2024535034A5
- Authority
- JP
- Japan
- Prior art keywords
- her2
- dose
- cancer
- approximately
- body weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163244690P | 2021-09-15 | 2021-09-15 | |
| US63/244,690 | 2021-09-15 | ||
| PCT/CA2022/051375 WO2023039672A1 (en) | 2021-09-15 | 2022-09-15 | Methods of treating cancer with anti-her2 biparatopic antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024535034A JP2024535034A (ja) | 2024-09-26 |
| JP2024535034A5 true JP2024535034A5 (https=) | 2025-09-18 |
Family
ID=85556873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024516626A Pending JP2024535034A (ja) | 2021-09-15 | 2022-09-15 | 抗ｈｅｒ２バイパラトピック抗体による癌治療方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250136714A1 (https=) |
| EP (1) | EP4401774A4 (https=) |
| JP (1) | JP2024535034A (https=) |
| KR (1) | KR20240058127A (https=) |
| CN (1) | CN117979996A (https=) |
| AU (1) | AU2022346447A1 (https=) |
| CA (1) | CA3177053A1 (https=) |
| CO (1) | CO2024004637A2 (https=) |
| IL (1) | IL311380A (https=) |
| MX (1) | MX2024003256A (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202508629A (zh) * | 2017-01-17 | 2025-03-01 | 美商建南德克公司 | 皮下her2抗體調配物 |
| CA3081503A1 (en) * | 2019-12-06 | 2021-06-06 | Zymeworks Inc. | Methods of using a bispecific antigen-binding construct targeting her2 in combination with cdk4/6 inhibitors for the treatment of breast cancer |
-
2022
- 2022-09-15 KR KR1020247010374A patent/KR20240058127A/ko active Pending
- 2022-09-15 MX MX2024003256A patent/MX2024003256A/es unknown
- 2022-09-15 US US18/692,278 patent/US20250136714A1/en active Pending
- 2022-09-15 CA CA3177053A patent/CA3177053A1/en active Pending
- 2022-09-15 EP EP22868500.4A patent/EP4401774A4/en active Pending
- 2022-09-15 AU AU2022346447A patent/AU2022346447A1/en active Pending
- 2022-09-15 CN CN202280062760.8A patent/CN117979996A/zh active Pending
- 2022-09-15 JP JP2024516626A patent/JP2024535034A/ja active Pending
- 2022-09-15 IL IL311380A patent/IL311380A/en unknown
-
2024
- 2024-04-12 CO CONC2024/0004637A patent/CO2024004637A2/es unknown